Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001206466-03-000001
Filing Date
2003-09-10
Accepted
2003-09-10 17:14:04
Documents
1
Period of Report
2003-06-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 2434
  Complete submission text file 0001206466-03-000001.txt   4613
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address NABI PHARMACEUTICALS 5800 PARK OF COMMERCE BLVD N.W. BOCA RATON FL 33487
Business Address NABI PHARMACEUTICALS 5800 PARK OF COMMERCE BLVD N.W. BOCA RATON FL 33487 5619895800
GURY DAVID J (Reporting) CIK: 0001206466 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-04829 | Film No.: 03890495